Medifast enters into $100M accelerated share repurchase agreement (NYSE:MED)
seekingalpha.com
business
2022-06-01 12:13:51

Medifast (NYSE:MED) is looking to repurchase $100M of its common stock through an accelerated share repurchase (ASR) agreement with JPMorgan Chase. This equates to ~600K shares, at the closing price on May 31, 2022, and represents ~5% of the company's fully diluted outstanding stock. As part of the program, Medifast (MED) will make an initial payment of $100M to JPM to receive an initial delivery of ~480K shares of its common stock. The program will be funded using available cash on hand and borrowings under the company's existing credit facility.
